Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Immunity, Weight Loss Supplement Marketers Risk FTC Scrutiny By Ignoring Industry Self-Regulation
Oct 01 2020
•
By
Eileen Francis
NAD, on a challenge by CRN, asked for substantiation for Optimmuner Plus ad claims including “balances the immune system response in autoimmune cases.”
More from Compliance
More from Policy & Regulation